Pathophysiology, risk, diagnosis, and management of venous thrombosis in space: where are we now?

Abstract

The recent incidental discovery of an asymptomatic venous thrombosis (VT) in the internal jugular vein of an astronaut on the International Space Station prompted a necessary, immediate response from the space medicine community. The European Space Agency formed a topical team to review the pathophysiology, risk and clinical presentation of venous thrombosis and the evaluation of its prevention, diagnosis, mitigation, and management strategies in spaceflight. In this article, we discuss the findings of the ESA VT Topical Team over its 2-year term, report the key gaps as we see them in the above areas which are hindering understanding VT in space. We provide research recommendations in a stepwise manner that build upon existing resources, and highlight the initial steps required to enable further evaluation of this newly identified pertinent medical risk.

Fig. 1. Suggested areas of research based on ESA Topical Team gap analysis.

Each box contains a research focus that will build towards better characterization of risk and/or management. The dependencies between the different research foci are shown by the arrows.